South China Center For Innovative Pharmaceuticals
3 clinical trials · Sponsor
◉ Watch South China Center For Innovative Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Pharmacokinetics of AD16 Tablets After MAD in Healthy Chinese Adult Subjects (NCT05806177) | South China Center For Innovative Pharmaceuticals | 2020-05-26 |
| The Effect of High Fat Diet on the Pharmacokinetics of AD16 Tablets in Healthy Chinese Adult Subjects (NCT05787041) | South China Center For Innovative Pharmaceuticals | 2019-06-14 |
| Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration (NCT05787028) | South China Center For Innovative Pharmaceuticals | 2019-01-30 |
Track South China Center For Innovative Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.